Related references
Note: Only part of the references are listed.Heart functional and structural compendium of cardiosplenic and cardiorenal networks in acute and chronic heart failure pathology
Ganesh V. Halade et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction
Andrew R. Kompa et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Combined Angiotensin Receptor-Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure
Rishi K. Trivedi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Structure of neprilysin in complex with the active metabolite of sacubitril
Nikolaus Schiering et al.
SCIENTIFIC REPORTS (2016)
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
Akshay S. Desai et al.
EUROPEAN HEART JOURNAL (2015)
Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy
Thomas G. von Lueder et al.
CIRCULATION-HEART FAILURE (2015)
Myofilament dysfunction contributes to impaired myocardial contraction in the infarct border zone
Rafael Shimkunas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Limiting Cardiac Ischemic Injury by Pharmacological Augmentation of Macrophage Migration Inhibitory Factor-AMP-Activated Protein Kinase Signal Transduction
Jingying Wang et al.
CIRCULATION (2013)
Renin-Angiotensin Blockade Combined With Natriuretic Peptide System Augmentation Novel Therapeutic Concepts to Combat Heart Failure
Thomas G. von Lueder et al.
CIRCULATION-HEART FAILURE (2013)
First-in-Class Angiotensin Receptor Neprilysin Inhibitor in Heart Failure
O. Vardeny et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth
Irina M. Jaba et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Connexin43 Gene Transfer Reduces Ventricular Tachycardia Susceptibility After Myocardial Infarction
Ian D. Greener et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
Scott D. Solomon et al.
LANCET (2012)
Accuracy and Reproducibility of Absolute Quantification of Myocardial Focal Tracer Uptake from Molecularly Targeted SPECT/CT: A Canine Validation
Yi-Hwa Liu et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Cell Communications in the Heart
Daniela Tirziu et al.
CIRCULATION (2010)
Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)
Jessie Gu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging
Lawrence W. Dobrucki et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
The natriuretic peptide/guanylyl cyclase-A system functions as a stress-responsive regulator of angiogenesis in mice
Michaela Kuhn et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
B-Type Natriuretic Peptide Enhances Vasculogenesis by Promoting Number and Functional Properties of Early Endothelial Progenitor Cells
Haim Shmilovich et al.
TISSUE ENGINEERING PART A (2009)
Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis
Xu Shi-Wen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium
Hongjie Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice
Daniela Tirziu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Molecular ablation of ventricular tachycardia after myocardial infarction
Tetsuo Sasano et al.
NATURE MEDICINE (2006)
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
I Shiojima et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro
H Kook et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration
K Yamahara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
